Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
Epidermolysis bullosa is a group of genetic skin conditions characterized by abnormal skin (and mucosal) fragility caused by pathogenic variants in various genes. The disease severity ranges from early childhood mortality in the most severe types to occasional acral blistering in the mildest types....
Enregistré dans:
Auteurs principaux: | Franciscus C. Vermeer, Jeroen Bremer, Robert J. Sietsma, Aileen Sandilands, Robyn P. Hickerson, Marieke C. Bolling, Anna M.G. Pasmooij, Henny H. Lemmink, Morris A. Swertz, Nine V.A.M. Knoers, K. Joeri van der Velde, Peter C. van den Akker |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/1311e30c58c5407bb9cef31de25b8743 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Digenic Mutations in Junctional Epidermolysis Bullosa in An Iranian Family
par: Kourosh Riahi, et autres
Publié: (2021) -
Kidney and Urinary Tract Involvement in Epidermolysis Bullosa: Is Routine Follow-Up Necessary?
par: Neslihan Cicek, et autres
Publié: (2021) -
Mitrofanoff continent vesicostomy as a treatment option for epidermolysis bullosa complicated by posterior urethral stenosis
par: A. Kissel, et autres
Publié: (2022) -
Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
par: Nadezhda A. Evtushenko, et autres
Publié: (2021) -
Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
par: Christina Guttmann-Gruber, et autres
Publié: (2021)